Financials | Financial Services | Capital Markets | Asset Management & Custody Banks
NASDAQ | Common Stock
Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses.
It intends to acquire businesses in the biotech industry.
The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021.
Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 21 | -0.00 | - |
| Jun 30, 21 | 0.00 | - |
| Mar 31, 21 | 0.00 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 0.00 Decreased by N/A% | -151.49 K Increased by +19.79% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -307.12 K Increased by +11.16% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -307.12 K Increased by +47.32% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -420.49 K Decreased by -230.94 K% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -188.87 K Decreased by -755.36 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 - | -345.70 K - | Decreased by N/A% - |
| Dec 31, 21 | 0.00 - | -583.02 K - | Decreased by N/A% - |
| Sep 30, 21 | 0.00 - | -182.00 - | Decreased by N/A% - |